Home/Filings/4/0001144204-17-059793
4//SEC Filing

Lemus David 4

Accession 0001144204-17-059793

CIK 0000850261other

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 7:22 PM ET

Size

5.7 KB

Accession

0001144204-17-059793

Insider Transaction Report

Form 4
Period: 2017-11-14
Lemus David
Director
Transactions
  • Award

    Stock Options

    2017-11-14+35,00035,000 total
    Exercise: $2.30Exp: 2027-11-14Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]1/12 of the original number of shares subject to this option is immediately vested and exercisable. 1/12 of the original number of shares subject to this option shall vest and become exercisable on November 26, 2017 and 1/12 of the original number of shares subject to the option shall vest following each one month of service thereafter, subject to the Reporting Person's continued service on the Issuer's board of directors on each such date.

Issuer

Sorrento Therapeutics, Inc.

CIK 0000850261

Entity typeother

Related Parties

1
  • filerCIK 0001717972

Filing Metadata

Form type
4
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 7:22 PM ET
Size
5.7 KB